Vektor Medical Receives FDA 510(k) Clearance Adding Atrial Flutter Mapping, Enhanced Connectivity and New Integration Capabilities to Next-Generation vMap Clearance Expands vMap’s Non-Invasive Mapping ...
Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ...
Please provide your email address to receive an email when new articles are posted on . Acutus Medical announced that its suite of new algorithms for the mapping and ablation of complex atrial ...
Boston Scientific announced that the FDA approved two navigation-enabled ablation catheters for treatment of type I atrial flutter. The magnetically tracked catheters (IntellaNav XP and IntellaNav ...
Clinical and demographic characteristics before catheter ablation, as well as data and follow-up outcome, have been prospectively collected in 105 patients with paroxysmal/persistent AF, including 40 ...
Catheter ablation is less successful for persistent atrial fibrillation than for paroxysmal atrial fibrillation. Guidelines suggest that adjuvant substrate modification in addition to pulmonary-vein ...
Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results